Preterm pregnant woman with COVID-19 associated with aggravated pre-eclampsia

Authors

Keywords:

COVID-19, caesarean section, preeclampsia, SARS-CoV-2, gynecology.

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by SARS-CoV-2, which can potentially cause severe acute respiratory syndrome and cause the death of the patient.
Objective: To present a patient with COVID -19 associated with aggravated preeclampsia, in a preterm pregnant woman.
Clinical case: A 25-year-old patient with a gestation of 35.2 weeks, a history of apparent health that was received since her arrival at the intensive care unit, referred for being positive for COVID-19, with respiratory symptoms of an associated lung disease, as high blood pressure figures, without other symptoms. Through physical examination and complementary humoral studies, an aggravated preeclampsia and oligohydramnios were diagnosed due to rupture of the ovular membranes. She was treated and compensated; Induction was started and during the procedure a risk of loss of fetal well-being was diagnosed, so it was decided to perform an urgent cesarean section. A healthy newborn was received. The patient did not present post-surgical complications and was treated according to current standards for cases of severe mother with COVID-19; she had a favorable evolution.
Conclusions: The early diagnosis and treatment of a pregnant woman with COVID-19 and associated preeclampsia allows a satisfactory evolution of the mother-fetus binomial.

Downloads

Download data is not yet available.

References

1. Centro de Medicina fetal-neonatal de Barcelona. Protocolo: Coronavirus (COVID-19) y gestación (V14 21/7/2021). España. 2021 [acceso: 22/09/2021]. Disponible en: https://medicinafetalbarcelona.org/protocolos/es/patologia-materna-obstetrica/covid19-embarazo.pdf

2. Martínez-González B, Garza-Reséndez N, Contreras-Garza NY. Combinación de riesgo: COVID-19 y preeclampsia. Serie de casos y revisión bibliográfica. Ginecol Obstet Mex. 2021 [acceso: 22/09/2021]; 89(08):622-634. Disponible en: https://www.medigraphic.com/pdfs/ginobsmex/gom-2021/gom218f.pdf

3. Smith V, Seo D, Warty R, Payne O, Salih M. Maternal and neonatal outcomes associated with COVID-19 infection. A systematic review. PLoS ONE. 2020 [acceso: 22/09/2021]; 15(6): e0234187. Disponible en: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0234187

4. Cruz-Lemini M, Ferriols Perez E, de la Cruz Conty ML, Caño Aguilar A, Encinas Pardilla MB. Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women. Viruses. 2021 [acceso: 22/09/2021]; 13(1):112. Disponible en: https://www.mdpi.com/1999-4915/13/1/112

5. Nápoles Méndez D, del Puerto Cruz A, Rodríguez García E, Piloto Padrón M, Castillo González D, Lim Alonso N. Principales emergencias obstétricas que causan ingreso en las unidades de cuidados intensivos. La Habana: Editorial Ciencias Médicas, 2021. [acceso: 22/09/2021]. Disponible en: http://www.bvs.sld.cu/libros/principales_emergencias_obstetricas/principales-_emergencias_obstetricas.pdf

6. Rodríguez-Brito A, Pérez D. OliveraCovid-19 y oportunidades para el bienestar materno-infantil en Cuba. Interface - Comunicação, Saúde, Educação. 2021 [acceso: 22/09/2021]; 25(Supl1): e200589. Disponible en: https://www.scielosp.org/pdf/icse/2021.v25suppl1/e200589/es

7. Esquivel I, Perez J, Duncan Y, et al. Effect and safety of combination of interferón alpha-2b for negativization of SARS-CoV-2 viral RNA. medRxiv. 2020 [preprint]. [acceso: 22/09/2021]. Disponible en: https://www.medrxiv.org/content/10.1101/2020.07.29.20164251v2.full.pdf

8. Perdigón Portieles CP, Hernández Toboso ML. Embarazo en tiempos de COVID-19, un acercamiento a la evidencia científica. Rev Cuba Obstetr Ginecol. 2020 [acceso: 22/09/2021]; 46(2): e634. Disponible en: http://www.revginecobstetricia.sld.cu/index.php/gin/article/view/634/575

Downloads

Published

2022-04-02

How to Cite

1.
Cardona Gonzalez H, Argilagos Casasayas G, Mourlot Ruiz A, Bonne Laborde JM, Martínez Arzola G. Preterm pregnant woman with COVID-19 associated with aggravated pre-eclampsia. Rev Cubana Med Milit [Internet]. 2022 Apr. 2 [cited 2025 Apr. 19];51(2):e02201719. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/1719

Issue

Vol. 51 No. 2 (2022): April - June

Section

Case Presentation

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.